Low-fat dairy consumption reduces systolic blood pressure, but does not improve other metabolic risk parameters in overweight and obese subjects

Nutr Metab Cardiovasc Dis. 2011 May;21(5):355-61. doi: 10.1016/j.numecd.2009.10.008. Epub 2010 Feb 13.

Abstract

Background and aims: Epidemiological studies have indicated a negative relation between low-fat dairy consumption and the metabolic syndrome. However, evidence from intervention studies is scarce. Our aim was to investigate the effects of daily consumption of low-fat dairy products on metabolic risk parameters in overweight and obese men and women.

Methods and results: Thirty-five healthy subjects (BMI>27 kg/m(2)) consumed low-fat dairy products (500 mL low-fat milk and 150 g low-fat yogurt) or carbohydrate-rich control products (600 mL fruit juice and 3 fruit biscuits) daily for 8 weeks in random order. Compared with the control period, systolic blood pressure was decreased by 2.9 mm Hg (95% confidence interval (CI), -5.5 to -0.3 mm Hg; P=0.027), while the difference in diastolic blood pressure did not reach statistical significance (95% CI, -3.4 to 0.3 mm Hg; P=0.090). Low-fat dairy consumption decreased HDL-cholesterol concentrations by 0.04 mmol/L (95% CI, -0.07 to -0.01 mmol/L; P=0.021) and apo A-1 concentrations by 0.04 g/L (95% CI, -0.07 to -0.01 g/L; P=0.016) compared with control. Serum total cholesterol, LDL-cholesterol, apo B, triacylglycerols, non-esterified fatty acids, glucose, insulin, C-reactive protein and plasminogen activator inhibitor-1 were unchanged.

Conclusion: We conclude that in overweight and obese subjects, daily intake of low-fat dairy products for 8 weeks decreased systolic blood pressure, but did not improve other metabolic risk factors related to the metabolic syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoprotein A-I / blood
  • Blood Glucose / analysis
  • Blood Pressure*
  • Body Composition
  • C-Reactive Protein / analysis
  • Cholesterol / blood
  • Cross-Over Studies
  • Dairy Products*
  • Diet, Fat-Restricted*
  • Dietary Fats / administration & dosage
  • Female
  • Humans
  • Insulin / blood
  • Male
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / diet therapy*
  • Middle Aged
  • Obesity / blood
  • Obesity / diet therapy*
  • Plasminogen Activator Inhibitor 1 / blood
  • Risk Factors
  • Triglycerides / blood

Substances

  • Apolipoprotein A-I
  • Blood Glucose
  • Dietary Fats
  • Insulin
  • Plasminogen Activator Inhibitor 1
  • Triglycerides
  • C-Reactive Protein
  • Cholesterol